Art

J-GLOBAL ID：201602228175530141   Reference number：16A1175947

IL-17A-producing CD30⁺ Vδ1 T cells drive inflammation-induced cancer progression

IL-17A-産生CD30⁺Vδ1 T細胞は炎症誘発性の癌の進行を促す

Author (15)： Kimura Yoshitaka (Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan) ,  Nagai Nao (Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan) ,  Tsunekawa Naoki (Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan) ,  Sato-Matsushita Marimo (Department of Surgery and Bioengineering, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan) ,  Yoshimoto Takayuki (Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan) ,  Cua Daniel J. (Pathway Biology, Merck Research Laboratories, Palo Alto, California, USA) ,  Iwakura Yoichiro (Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan) ,  Yagita Hideo (Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan) ,  Okada Futoshi (Division of Pathological Biochemistry, Tottori University Faculty of Medicine, Yonago, Tottori, Japan) ,  Okada Futoshi (Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan) ,  Tahara Hideaki (Department of Surgery and Bioengineering, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan) ,  Saiki Ikuo (Division of Pathogenic Biochemistry, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Toyama, Japan) ,  Irimura Tatsuro (Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan) ,  Hayakawa Yoshihiro (Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan. [e-mail]) ,  Hayakawa Yoshihiro (Division of Pathogenic Biochemistry, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Toyama, Japan. [e-mail])
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 107  Issue： 9  Page： 1206-1214  Publication year： 2016 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *CD antigen ,...
Semi thesaurus term： *CD30 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1175947&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： CD30 ,  IL-17 ,  IL-1β ,  neutrophil ,  γδ T cell

JST classification (1)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Reference (41)：

• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-74.
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883 -99.
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13: 759-71.
• Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011; 34: 149-62.
• Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11: 763-76.

Terms in the title (4)： IL-17A ,  T細胞 ,  炎症 ,  癌